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Abstracts
Gregory L. Moneta, MD, Section EditorInﬂuence of Race on the Management of Lower Extremity Ischemia:
Revascularization vs Amputation
Durazzo TS, Frencher S, Gusberg R. JAMA Surg 2013;148:617-23.
Conclusions: Black patients have greater odds of undergoing ampu-
tation than white patients. This is even after correcting for an array of con-
founding parameters. Disparity is magniﬁed in settings where resources are
greatest.
Summary: A number of studies have suggested that among patients
with critical lower extremity ischemia (CLI), white patients are more likely
to undergo an attempt at limb salvage with revascularization than nonwhite
patients, who are more likely to undergo amputation (Gornick ME et al,
N Engl J Med 1996;335:791-9; and Feinglass J et al, J Vasc Surg
2005;41:823-9). Possible explanations for these differences in patterns of
care have been broadly categorized as institutional-level, patient-level,
and health care provider-level factors. Differences in amputation rates
between white and nonwhite patients have largely been attributed to differ-
ences in access to care. The suggestion is that nonwhite patients have less
access to hospitals and physicians capable of providing high-quality revascu-
larization procedures. The authors sought to investigate factors that may
contribute to a racial disparity in amputation rates. They focused on several
questions: (1) Are there signiﬁcant differences in the type of hospital with
respect to capacity to perform advanced revascularization procedures at
which white and nonwhite patients with lower extremity ischemia receive
care? (2) Are there differences in hospital capabilities that independently
effect racial disparity in treatment? And using wealth of zip code areas as
an indicator of local resources, (3) Do local resources have an independent
impact on racial disparities in care of the patient with CLI? The authors
used all hospital discharge records from the Nationwide Inpatient Sample
of adult patients with a primary diagnosis of CLI from 2002 to 2008.
There were 774,399 records examined with multiple logistic regression
analysis. Controlling for confounding factors, black patients had 1.77 times
the odds of receiving an amputation compared with white patients (95%
conﬁdence interval [CI], 1.72-1.84; P < .001). Paradoxically, additional
analysis revealed the black-to-white odds ratio increased with increasing
revascularization capacity of the treating hospital, from a low of 1.43
(95% CI, 1.23-1.65) to a high of 1.98 (95% CI, 1.83-2.24). Surprisingly,
amputation disparity by race also increased for patients living in wealthier
zip codes.
Comment: In this study of patients with CLI, being black, indepen-
dent of other variables, increased the odds of amputation by 78%. White
patients, those with private insurance, those living in the wealthiest zip
codes, and those cared for at teaching hospitals all independently had
increased odds of revascularization. However, racial disparity between
amputations in black and white patients was highest within hospitals with
the greatest capacity for revascularization and was greater among those
residing in wealthier zip codes. The ﬁnal conclusion is that it is not neces-
sarily access to health care but race-speciﬁc factors with respect to CLI
that are most important in determining amputation rate. Although there
are certainly problems with data dredging from large multi-institution data-
bases, the concept that biologic rather than social differences contribute to
outcomes in patients with vascular disease, particularly those with lower
extremity ischemia, deserves further investigation.
Comparison of Outcomes for Open Abdominal Aortic Aneurysm
Repair and Endovascular Repair in Patients With Chronic Renal
Insufﬁciency
Nguyen BN, Neville RF, Rahbar R, et al. Ann Surg 2013;258:394-9.
Conclusions: Endovascular aneurysm repair (EVAR) should be
preferred over open aneurysm repair (OPEN) in patients with moderate
renal dysfunction provided there is appropriate anatomy for EVAR. High
postoperative complications in patients with abdominal aortic aneurysm
(AAA) treated with either OPEN or EVAR suggest the need for a higher
threshold for AAA repair in patients with renal insufﬁciency.
Summary: Renal insufﬁciency is an independent predictor of early
and late mortality after OPEN AAA repair and EVAR (Ohrlander T et
al, Vasc Med 2011;16:422-7; and Mills JL Sr, et al, J Vasc Surg
2008;47:1141-9). Use of intra-arterial contrast with EVAR and infollow-up is also postulated to result in up to a 10% decrease in creatinine
clearance after the ﬁrst year (Alsac JM et al, J Vasc Surg 2005;41:926-30).
However, up to 20% of AAA patients with OPEN repair also have
a decrease in renal function postoperatively (Nathan DP et al, J Vasc
Surg 2011;54:1237-43). In this study, the authors used the National
Surgical Quality Improvement Program (NSQIP) database to determine
which approach, EVAR or OPEN, for AAA repair is preferable in patients
with renal insufﬁciency. The NSQIP database from 2005 to 2010 was
used to identify patients who underwent EVAR and OPEN repair for
infrarenal AAA during that time period. The preoperative estimated
glomerular ﬁltration rate (eGFR) was calculated by the Chronic Kidney
Disease Epidemiology Collaboration equation. Patients with chronic renal
insufﬁciency were stratiﬁed into two groups: moderate (eGFR ¼ 30-60
mL/min) and severe (eGFR <30 mL/min) renal dysfunction. A multivar-
iate regression model was used for data analysis. There were 13,191
patients identiﬁed who underwent AAA repair, 9877 who underwent
EVAR, and 3314 who underwent OPEN repair. The eGFR in 40% of
patients was <60 mL/min. Overall, EVAR patients had lower 30-day
mortality (odds ratio, 3.74; 95% conﬁdence interval, 2.63-5.32; P <
.001). EVAR patients were also less likely to have renal, pulmonary, or
cardiovascular events and less likely to have combined postoperative events
(odds ratios of 3.0, 5.5, 2.0, and 4.3, respectively; P < .001 for all). In
patients with moderate renal dysfunction, OPEN repair had a 3.6-times
higher risk of postoperative renal impairment and a 5.1-times higher risk
of dialysis than EVAR. In patients with severe renal dysfunction, there
was no beneﬁt of EVAR over OPEN repair, with both methods of repair
having signiﬁcantly higher complication rates than in patients with
moderate renal dysfunction.
Comment: The discussants of the paper at the Annual Meeting of
the American Surgical Association pointed out two key questions relevant
to the paper. The ﬁrst was without knowing the anatomy of the aneu-
rysms in the OPEN and EVAR groups, it is difﬁcult to compare the
two groups, in that, presumably, there may be anatomic reasons why
OPEN repair was performed over EVAR that could inﬂuence postopera-
tive complication rates. The relative safety of EVAR vs OPEN repair in
patients with renal insufﬁciency therefore may be exaggerated by differ-
ences in anatomy. Nevertheless, as Dr Ricotta points out, this paper
does indicate that one can safely perform EVAR in patients with moderate
renal insufﬁciency.
Association Between Advanced Age and Vascular Disease in Different
Arterial Territories: A Population Database of Over 3.6 Million
Subjects
Savji N, Rockman CB, Skolnick AH, et al. J Am Coll Cardiol 2013;61:
1736-43.
Conclusions: More than 20% and 30% of octogenarians and nonage-
narians, respectively, have vascular disease in at least one arterial territory.
Summary: Much of the data concerning the epidemiology of vascular
disease derives from meta-analysis or from small screening studies that have
only small numbers of octogenarians and nonagenarians. However,
increasing age is a well-known risk factor for atherosclerosis. The precise
association of advanced age with vascular disease of different peripheral arte-
rial locations has not been studied in detail. The authors used a group of
>3.6 million individuals to determine the relationship between advanced
age and vascular disease with respect to lower extremity peripheral arterial
disease (PAD), carotid artery stenosis, and abdominal aortic aneurysm,
with prevalence stratiﬁed by decade of life. The study was based on data
provided by Life Line Screening Inc (Independence, Ohio) to the Society
for Vascular Surgery for research purposes. Participants in Life Line
Screening are self-referred individuals who pay out-of-pocket for vascular
screening tests. The data incorporated screenings from 2003 to 2008
from >20,000 sites nationwide. Individuals being screened completed
a medical and lifestyle questionnaire and were evaluated by ankle-brachial
indices, with <0.90 indicating PAD, ultrasound imaging for carotid artery
stenosis >50%, and abdominal aortic aneurysm, deﬁned as an abdominal
aorta $3 cm. Multivariate logistic regression analysis was used to estimate
odds of disease in different age categories. Overall, prevalence of PAD,1719
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0.9%, respectively. Prevalence of vascular disease increased with age (40-50
years: 2%, 51-60 years: 3.5%, 61-70 years: 7.1%, 71-80 years: 13.0%, 81-90
years: 22.3%, 91-100 years: 32.5%; P < .0001). The prevalence of vascular
disease in each vascular territory also increased with age. After adjustment
for sex, race-ethnicity, body mass index, family history of cardiovascular
disease, smoking, diabetes, hypertension, hypercholesterolemia, and exer-
cise, the odds of PAD (odds ratio [OR], 2.14; 95% conﬁdence interval
[CI], 2.12-2.15), carotid artery stenosis (OR, 1.8; 95% CI, 1.79-1.81),
and abdominal aortic aneurysm (OR, 2.33; 95% CI, 2.30-2.36) increased
with each decade of life.
Comment: Age is a well-known risk factor for atherosclerosis. The
data here, if anything, are likely to underestimate the prevalence of vascular
disease. Patients who present for screening studies, the so-called worried
well, may be more health oriented and live healthier lifestyles than those
who do not. After all, patients known to have vascular disease are not really
candidates for “screening” studies and, theoretically, would not be included
in the database. It seems they would be unlikely to pay for an examination to
conﬁrm what they already know.
Fistula First Is Not Always the Best Strategy for the Elderly
DeSilva RN, Patibandla BK, Vin Y, et al. J Am Soc Nephrol 2013;24:
1297-304.
Conclusions: Fistula ﬁrst is not clearly superior to graft ﬁrst in very
elderly patients. Each strategy is associated with similar mortality outcomes
in octogenarians and nonagenarians.
Summary: In patients requiring hemodialysis, one-third of ﬁstulas
fail to mature (Allon M et al, Kidney Int 2002;62:1109-24). In addition,
patients aged >65 years have twice the failure rate of younger patients
(Lok CE et al, J Am Soc Nephrol 2006;17:3204-12). A higher rate of
ﬁstulas that fail to mature may contribute to greater use of catheters.
Indeed, from the mid-1990s until recently, incident use of arteriovenous
(AV) grafts in elderly patients decreased from 28.2% to 4.2%, but at the
same time, incident catheter use increased from 56.8% to 82.3% (DeSilva
RN et al, Hemodial Int 2012;16:233-41; and Lacson E Jr et al, Am J
Kidney Dis 2009;54:912-21). Along with this, it is noted that the incident
hemodialysis population is aging, with an annual increase of 8% to 16% in
patients aged >75 years. In this paper, the authors sought to determine
mortality rates in the elderly population according to the initial type of
vascular access placed rather than the access used at initiation of hemodi-
alysis. The speciﬁc question was whether ﬁstula ﬁrst, as an intention-to-
treat strategy might not be the clearly superior predialysis vascular access
placement strategy in octogenarians. The paper analyzed data from
a cohort of 115,425 incident hemodialysis patients who were aged $65
years. Data were derived from the US Renal Data System with linked
Medicare claims. This allowed identiﬁcation of the ﬁrst predialysis vascular
access placed rather than just the ﬁrst access used for hemodialysis. All-
cause mortality outcomes based on the ﬁrst vascular access placed were
evaluated using proportional hazard models. The ﬁstula group was the
reference. In the study population, 21,436 patients had ﬁstulas as the ﬁrst
predialysis access placed, 3472 had grafts as the ﬁrst predialysis access, and
90,517 had catheters as the ﬁrst predialysis access. Patients with catheters
as their ﬁrst predialysis access demonstrated inferior survival compared
with patients with a ﬁstula (hazard ratio [HR], 1.77; 95% conﬁdence
interval [CI], 1.73-1.81; P < .001). There was no signiﬁcant difference
in mortality between patients with a graft as the ﬁrst access placed and
those with a ﬁstula as the initial access (HR, 1.05; 95% CI, 1.00-1.11;
P ¼ .06). Patients with grafts as their ﬁrst predialysis access had inferior
mortality outcomes compared with ﬁstulas for the group aged 67 to
#79 years (HR, 1.10; 95% CI, 1.02-1.17; P ¼ .007). However, differ-
ences between graft-ﬁrst and ﬁstula-ﬁrst groups were not statistically signif-
icant for the groups aged 80 to #89 years those aged >90 years. Overall,
only 50.7% of elderly patients with an AV ﬁstula placed ﬁrst used an AV
ﬁstula at the time of hemodialysis initiation. A higher percentage of those
patients within the AV ﬁstula-ﬁrst group used catheters at dialysis initiation
compared with the AV graft-ﬁrst group (43% vs 25%).
Comment: It is becoming increasingly evident that a ﬁstula-ﬁrst
strategy as a blanket strategy may not be appropriate for all patients
approaching hemodialysis. The authors’ data argue strongly for the fact
that perhaps what is more important is avoiding a catheter in the elderly
patient rather than whether hemodialysis is initiated with a ﬁstula or a graft.
The observational data here suggest placing an AV graft ﬁrst decreases the
chance of initiating hemodialysis with a catheter compared with a ﬁstula-ﬁrst
strategy. The clinical implication is that a ﬁstula-ﬁrst strategy should be used
in elderly patients who have a high chance for a successful ﬁstula but that the
remainder of patients should be considered for a graft to initiate
hemodialysis.Systematic Review and Meta-Analysis of Additional Technologies To
Enhance Angioplasty for Infrainguinal Peripheral Arterial Occlusive
Disease
Simpson EL, Michaels JA, Thomas SM, et al. Br J Surg 2013;100:
1128-37.
Conclusions: Among technologies available to enhance conventional
percutaneous transluminal balloon angioplasty (PTA), self-expanding stents,
drug-eluting stents, and drug-coated balloons appear to be the most prom-
ising technologies for future study.
Summary: There are a number of modiﬁcations of balloon angio-
plasty aimed at improving success of the initial recanalization and prevention
of late restenosis in the percutaneous treatment of infrainguinal peripheral
arterial occlusive disease. These technologies include stents, laser angio-
plasty, arthrectomy devices, drug-eluting stents, drug-coated balloons,
endovascular radiotherapy, and brachytherapy. This review is part of a larger
project looking at enhancements to angioplasty (Simpson EL et al, http://
www.hta.ac.uk/project/2324.asp). The purpose of the review was to eval-
uate the range of available additional technologies to enhance results of
infrainguinal PTA. The authors searched relevant electronic databases in
May 2011. The patient population studied was those with symptomatic
peripheral arterial occlusive disease undergoing endovascular treatment for
disease distal to the inguinal ligament. Interventions were additional tech-
niques compared with conventional PTA. Need for reintervention and
restenosis were the main outcome measures. Randomized clinical trials
were assessed for quality, and data were extracted to determine clinical effec-
tiveness. Where appropriate, meta-analysis was undertaken to produce risk
ratios (RRs). There were 40 randomized clinical trials selected. Meta-anal-
ysis showed a signiﬁcant beneﬁt at 6 months in reducing restenosis for
self-expanding stents (RR, 0.49) and drug-coated balloons (RR, 0.40)
and at 12 months for endovascular brachytherapy (RR, 0.63). Stent grafts
also signiﬁcantly reduced stenosis compared with PTA, as did drug-eluting
stents compared with bare-metal stents. The meta-analysis showed drug-
coated balloons were associated with lower reintervention rates than PTA
alone at 6 months (RR, 0.24) and at 24 months (RR, 0.27). Self-expanding
stents at 6 months also appeared to result in lower reintervention rates.
Other techniques did not show signiﬁcant treatment effects for restenosis
or reintervention.
Comment: It seems that every few months there is a new “wonder
technique” to reduce restenosis and reintervention in patients undergoing
percutaneous treatment of infrainguinal arteries. Although the conclusions
of this review must be tempered by small sample sizes and, frequently, by
lack of clinical outcome measures permitting direct comparison between
trials, it does appear not all adjuncts to balloon angioplasty are equal.
Because there are limited resources available for study of these adjuncts,
the value of this review is to identify those adjuncts most likely to have
beneﬁt when studied with respect to patient-oriented outcomes such as
measures of quality of life, reintervention, and symptomatic recurrence.
Myocardial Injury After Noncardiac Surgery and its Association With
Short-Term Mortality
van Waes JAR, Nathoe HM, de Graaff JC, et al; and the Cardiac Health
After Surgery (CHASE) Investigators. Circulation 2013;127:2264-71.
Conclusions: Postoperative myocardial injury is an independent
predictor of 30-day mortality after noncardiac surgery.
Summary: In high-risk surgical patients, isolated troponin elevations
are strong independent predictors of mortality within the ﬁrst year after
surgery (Levy M et al, Anesthesiology 2001;114:796-806). The VISION
study (Vascular Events in Noncardiac Surgery Patients Cohort Evaluation)
included >15,000 surgical patients and showed a strong association
between peak troponin levels postoperatively and 30-day mortality (Dever-
eaux PJ et al, JAMA 2012;307:2295-304). On the basis of the VISION
study, it has been suggested that routine postoperative troponin monitoring
could be implemented as standard of care in appropriate patients under-
going noncardiac surgery to provide better risk stratiﬁcation and long-
term patient management. The authors therefore sought to determine
the predictive value of postoperative troponin elevation with respect to
30-day mortality after noncardiac surgery. This was an observational
single-center cohort study of 2232 noncardiac surgical patients considered
intermediate-risk to high-risk. Patients were aged $60 years and underwent
surgery in 2011. Troponin was measured for the ﬁrst 3 postoperative days.
The association between postoperative myocardial injury (troponin I level
>0.06 mg/L) and all-cause 30-day mortality was determined using log
binomial regression analysis. Of the 1627 patients in whom troponin was
measured, 315 (19%) had myocardial injury as indicated by an elevated
troponin I level. All-cause death occurred in 56 patients (3%). The relative
risk of a minor increase in troponin (0.07-0.59 mg/L) was 2.4 (95% conﬁ-
dence interval, 1.3-4.2; P < .01). The relative risk of a 10- to 100-fold
